Massivemarkets

SEPN

Septerna, Inc. Common Stock

Nasdaq · usd

$40.02-1.65 (-3.96%)
At close · 15-minute delayed
$39.24-0.78 (-1.95%)
As of 7:40:59 PM EST on Nov 17, 2026 · After hours

Septerna, Inc. Common Stock (SEPN) trades at $40.02 (-3.96%) as of 7:40:59 PM EST on Nov 17, 2026, +10.01% over the past month. Market cap is $1.98B, with 11.9 days to cover in short interest.

Stock performance

How Septerna, Inc. Common Stock (SEPN) stock has performed from one day to one year, with its 52-week range.

-3.26%
-$1.35 over 1D
$39.52$40.09$40.67$41.249:30 AM11:20 AM1:00 PM2:30 PM8:00 PM$40.02
1D
-3.96%
1W
-23.54%
1M
+10.01%
YTD
+43.54%
1Y
+84.51%
52-wk range
$21.31 – $53.34

Key statistics

Today's trading snapshot for SEPN: day range, open, previous close, volume and market cap.

Day range
$39.28 – $41.67
Open
$41.67
Prev close
$41.67
Volume
271.76K
Market cap
$1.98B
Shares out
47.55M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Septerna, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
20.58
P/B
4.63
P/FCF
—
ROE
-13.8%
ROA
-9.5%
Debt/Equity
0.00
Div yield
0.00%

As of Nov 16, 2026

8-K filings

Material corporate events Septerna, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • On November 09, 2026, Septerna, Inc. (the "Company") announced its financial results and business highlights for the quarter ended September 30, 2026.

  • Business updateNov 4, 2026

    On November 4, 2026, Septerna, Inc. issued a press release titled "Septerna Announces Selection of SEP-204 as Development Candidate for Graves' Disease and TED and Reports Preclinical Data at the 2026 American Thyroid Association Annual Meeting."

  • Executive officer appointmentAug 25, 2026

    Effective August 24, 2026, the Company's Board of Directors appointed Rajiv Patni, M.D., as the Company's Chief Medical Officer.

  • Annual meeting resultsJun 30, 2026

    The Company's stockholders elected Shalini Sharp, M.B.A. and Jake Simson, Ph.D. to the Company's Board of Directors (the "Board") as Class II directors, each for a three-year term ending at the annual meeting of stockholders of the Company to be held in 2029. The results of the stockholders' vote with respect to the election of the Class II directors were as follows: [vote tallies provided].

  • Investor presentationApr 13, 2026

    The Company also updated its corporate presentation for use in meetings with investors, analysts and others. A copy of the updated corporate presentation is furnished as Exhibit 99.2 to this Current Report on Form 8-K.

SEPN short interest

How heavily SEPN is shorted: shares short, days to cover and average daily volume.

Days to cover
11.9
Short interest
3.35M
Avg volume
280.56K

As of · reported to FINRA twice monthly.

SEPN news

The latest news and headlines about Septerna, Inc. Common Stock (SEPN).

Frequently asked questions

What is the Septerna, Inc. Common Stock (SEPN) stock price today?

Septerna, Inc. Common Stock (SEPN) is trading at $40.02 (-3.96% on the day) as of 7:40:59 PM EST on Nov 17, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Septerna, Inc. Common Stock?

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform.

What is the short interest in SEPN?

As of Oct 30, 2026, SEPN has 3.35M shares short and 11.9 days to cover.

What exchange is SEPN listed on?

Septerna, Inc. Common Stock (SEPN) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

Build with AI

Build an analysis of SEPN with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a SEPN analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.